First human gets experimental gene shot to rewind ageing cells in the eye Life Biosciences has dosed its first patient with ER-100, a treatment that uses partial cellular reprogramming to target ...

Test time has arrived: the first person has been treated in a highly anticipated gene-therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial is testing an ...

Researchers are decoding how signals move between body and brain, with implications for how we understand and treat ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

A Boston biotech company has administered what researchers are describing as the first human dose of a cellular rejuvenation drug, a milestone in the effort to treat age-related disease at the ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. A first-of-its-kind shot that promises to reverse aging was just injected into a human body. It's a ...

A first-of-its-kind shot that promises to reverse aging was just injected into a human body. It's a pivotal moment for longevity science, the first opportunity for researchers to prove that epigenetic ...

South Korean researchers have identified a new therapeutic target that could help overcome the limitations of anti-angiogenic ...

Signal transduction and gene regulation are at the heart of cell and developmental biology, driving cell fate decisions and tissue homeostasis. In cancer, ...

IOWA’S NEWS LEADER. ALL RIGHT. BO. THANK YOU. NEW AT SIX. NEARLY 500 U.S. CELLULAR EMPLOYEES IN IOWA WILL LOSE THEIR JOBS IN JUNE. THAT’S ACCORDING TO IOWA WORKFORCE DEVELOPMENT HERE IN THE CENTRAL ...